TestCard has developed a self-diagnostic urine test kit for testing at home. The prototype diagnostic urinalysis urine test kit is embedded into a postcard with a pop-out urine test panel. The test kit cards come in a pouch that contains the urine test kits to test glucose level, malaria, and urinary tract infection. The company operates in the Disease Self Management sector with additional focus on Wearable Technology and Wearable Technology. Its business model centers on Remote Patient Monitoring. Founded in 2016, headquartered in London, United Kingdom. The company has raised $20.2M at the Series B stage. Backed by investors including Neo Ventures, Springtime Consultancy, Wayra.co.uk, West Hill Capital, Parkpine Capital and others.
← All startups
TestCard
Series BTestCard has developed a self-diagnostic urine test kit for testing at home. The prototype diagnostic urinalysis urine test kit is embedded into a postcard with a pop-out urine test panel. The test kit cards come in a pouch that contains the urine test kits to test glucose level, malaria, and urinary tract infection. The company operates in the Disease Self Management sector with additional focus on Wearable…
About
Business model
Wearable Technology > Health and Wellness Devices > Remote Patient Monitoring,
Disease Self Management > Body Health Parameters > Monitoring > Body Vitals > Device,
Healthcare IT > Value Based Care > Remote Monitoring > At Home Virtual Hospital
Institutional investors
Neo VenturesSpringtime ConsultancyWayra.co.ukWest Hill CapitalParkpine CapitalPlug and Play Tech CenterOP6 InnovationAl Dhow CapitalEPRVICP GroupStartup CreasphereChris Craig-WoodGeorge SutherlandSven WolfArtur Sychov
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ Explore HealthTech investors — funds that write checks in this sector.